Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element
Yi Luo, Alan R. Tall
Yi Luo, Alan R. Tall
Published February 15, 2000
Citation Information: J Clin Invest. 2000;105(4):513-520. https://doi.org/10.1172/JCI8573.
View: Text | PDF
Article Article has an altmetric score of 3

Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element

  • Text
  • PDF
Abstract

The cholesterol ester transfer protein (CETP) facilitates the transfer of HDL cholesterol esters from plasma to the liver. Transgenic mice expressing human CETP, controlled by its natural flanking region, increase expression of this gene in response to hypercholesterolemia. We established a CETP promoter-luciferase reporter assay in differentiated 3T3-L1 adipocytes to map the sterol upregulatory element. Promoter mutagenesis suggested that a direct repeat of a nuclear receptor binding sequence separated by 4 nucleotides (DR4 element, –384 to –399) was responsible for this activity. Using mice carrying normal or mutated promoter sequences, we confirmed the importance of this element for gene induction by dietary sterol. A gel retardation complex containing LXR/RXR was identified using the CETP DR4 element and adipocyte nuclear extracts. Both LXRα/RXRα and LXRβ/RXRα transactivated the CETP promoter via its DR4 element in a sterol-responsive fashion. Thus, the positive sterol response of the CETP gene is mediated by a nuclear receptor binding site that is activated by LXRs. That Cyp7a, the rate-limiting enzyme for conversion of cholesterol into bile acids in the liver, is also regulated by LXRα suggests that this class of nuclear receptor coordinates the regulation of HDL cholesterol ester catabolism and bile acid synthesis in the liver.

Authors

Yi Luo, Alan R. Tall

×

Total citations by year

Year: 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1997 1989 Total
Citations: 3 4 2 1 10 4 6 3 7 5 23 2 13 8 15 13 20 5 15 9 12 33 24 21 17 1 1 277
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (277)

Title and authors Publication Year
Future therapeutic perspectives in nonalcoholic fatty liver disease: a focus on nuclear receptors, a promising therapeutic target
Stan SI, Biciuşcă V, Clenciu D, Mitrea A, Boldeanu MV, Durand P, Dănoiu S
Medicine and pharmacy reports 2024
Damaging mutations in liver X receptor-α are hepatotoxic and implicate cholesterol sensing in liver health.
Lockhart SM, Muso M, Zvetkova I, Lam BYH, Ferrari A, Schoenmakers E, Duckett K, Leslie J, Collins A, Romartínez-Alonso B, Tadross JA, Jia R, Gardner EJ, Kentistou K, Zhao Y, Day F, Mörseburg A, Rainbow K, Rimmington D, Mastantuoni M, Harrison J, Nus M, Guma'a K, Sherratt-Mayhew S, Jiang X, Smith KR, Paul DS, Jenkins B, Koulman A, Pietzner M, Langenberg C, Wareham N, Yeo GS, Chatterjee K, Schwabe J, Oakley F, Mann DA, Tontonoz P, Coll AP, Ong K, Perry JRB, O'Rahilly S
Nature metabolism 2024
The Composition of the HDL Particle and Its Capacity to Remove Cellular Cholesterol Are Associated with a Reduced Risk of Developing Active Inflammatory Rheumatoid Arthritis.
Giacaglia MB, Felix VP, Santana MFM, Amendola LS, Lerner PG, Fernandes SDE, Camacho CP, Passarelli M
International journal of molecular sciences 2024
Development of LXR inverse agonists to treat MAFLD, NASH, and other metabolic diseases.
Griffett K, Burris TP
Frontiers in Medicine 2023
Structure-based mechanism and inhibition of cholesteryl ester transfer protein.
Xue H, Zhang M, Liu J, Wang J, Ren G
Current Atherosclerosis Reports 2023
Targeting Liver X Receptors for the Treatment of Non-Alcoholic Fatty Liver Disease
Kim H, Park C, Kim TH
Cells 2023
The roles of nuclear receptors in cholesterol metabolism and reverse cholesterol transport in nonalcoholic fatty liver disease
Li Z, Zheng D, Zhang T, Ruan S, Li N, Yu Y, Peng Y, Wang D
Hepatology Communications 2023
Expressing the Human Cholesteryl Ester Transfer Protein Minigene Improves Diet-Induced Fatty Liver and Insulin Resistance in Female Mice.
Zhu L, An J, Chinnarasu S, Luu T, Pettway YD, Fahey K, Litts B, Kim HH, Flynn CR, Linton MF, Stafford JM
Frontiers in physiology 2022
Clinical diversity and molecular mechanism of VPS35L-associated Ritscher-Schinzel syndrome.
Otsuji S, Nishio Y, Tsujita M, Rio M, Huber C, Antón-Plágaro C, Mizuno S, Kawano Y, Miyatake S, Simon M, van Binsbergen E, van Jaarsveld RH, Matsumoto N, Cormier-Daire V, J Cullen P, Saitoh S, Kato K
Journal of medical genetics 2022
Liver X receptors and liver physiology
L Russo-Savage, IG Schulman
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2021
Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease
XC Jiang
2020
Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease
XC Jiang
2020
Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease
XC Jiang
2020
Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease
XC Jiang
2020
Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease
XC Jiang
2020
Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease
XC Jiang
2020
Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease
XC Jiang
2020
Hydrogen sulfide accumulates LDL receptor precursor via downregulating PCSK9 in HepG2 cells
Y Huang, K Ning, WW Li, G Lin, CL Hou, MJ Wang, YC Zhu
American journal of physiology. Cell physiology 2020
Identification of a hormone response element that mediates suppression of APOF by LXR and PPARα agonists
Y Liu, L Izem, RE Morton
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2020
Mammalian Sterols: Novel Biological Roles of Cholesterol Synthesis Intermediates, Oxysterols and Bile Acids
D Rozman, R Gebhardt
2020
Cholesterol and Its Metabolites in Tumor Growth: Therapeutic Potential of Statins in Cancer Treatment
A Chimento, I Casaburi, P Avena, F Trotta, AD Luca, V Rago, V Pezzi, R Sirianni
Frontiers in Endocrinology 2019
Hepatic triglyceride content does not affect circulating CETP: lessons from a liraglutide intervention trial and a population-based cohort.
van Eyk HJ, Blauw LL, Bizino MB, Wang Y, van Dijk KW, de Mutsert R, Smit JWA, Lamb HJ, Jazet IM, Rensen PCN
Scientific Reports 2019
Activation of liver X receptor promotes fatty acid synthesis in goat mammary epithelial cells via modulation of SREBP1 expression
HF Xu, J Luo, XY Zhang, J Li, M Bionaz
Journal of Dairy Science 2019
Niacin regulates apolipoprotein M expression via liver X receptor‑α
L Yang, T Li, S Zhao, S Zhang
Molecular medicine reports 2019
Natural products as modulators of the nuclear receptors and metabolic sensors LXR, FXR and RXR
V Hiebl, A Ladurner, S Latkolik, VM Dirsch
Biotechnology Advances 2018
Liver X receptors in lipid signalling and membrane homeostasis
B Wang, P Tontonoz
Nature Reviews Endocrinology 2018
Lipopolysaccharide Lowers Cholesteryl Ester Transfer Protein by Activating F4/80 + Clec4f + Vsig4 + Ly6C − Kupffer Cell Subsets
SJ van der Tuin, Z Li, JF Berbée, I Verkouter, LE Ringnalda, AE Neele, JB van Klinken, SS Rensen, J Fu, MP de Winther, AK Groen, PC Rensen, KW van Dijk, Y Wang
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2018
Cholesteryl ester transfer protein and its inhibitors
S Shrestha, BJ Wu, L Guiney, PJ Barter, KA Rye
Journal of lipid research 2018
Cholesterol Metabolism Is Enhanced in the Liver and Brain of Children With Citrin Deficiency
S Hirayama, H Nagasaka, A Honda, H Komatsu, T Kodama, A Inui, I Morioka, S Kaji, T Ueno, K Ihara, M Yagi, Z Kizaki, K Bessho, H Kondou, T Yorifuji, H Tsukahara, K Iijima, T Miida
The Journal of clinical endocrinology and metabolism 2018
Metabolic liver inflammation in obesity does not robustly decrease hepatic and circulating CETP
LL Blauw, Z Li, SS Rensen, JW Greve, A Verhoeven, RJ Derks, M Giera, Y Wang, PC Rensen
Atherosclerosis 2018
Targeting bile acids and lipotoxicity for NASH treatment: Chiang
JY Chiang
Hepatology Communications 2017
Liver X Receptor Gene Expression is Enhanced in Children with Obstructive Sleep Apnea-Hyperpnoea Syndrome and Cyclooxygenase-2 (COX-2) is Correlated with Severity of Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS)
XH Ye, H Chen, Q Yu, QL Zhu
Medical science monitor : international medical journal of experimental and clinical research 2017
Liver X Receptor Gene Expression is Enhanced in Children with Obstructive Sleep Apnea-Hyperpnoea Syndrome and Cyclooxygenase-2 (COX-2) is Correlated with Severity of Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS).
Ye XH, Chen H, Yu Q, Zhu QL
Medical science monitor : international medical journal of experimental and clinical research 2017
Once and for all, LXRα and LXRβ are gatekeepers of the endocrine system
S Maqdasy, A Trousson, I Tauveron, DH Volle, S Baron, JM Lobaccaro
Molecular Aspects of Medicine 2016
Beneficial and Adverse Effects of an LXR Agonist on Human Lipid and Lipoprotein Metabolism and Circulating Neutrophils
TG Kirchgessner, P Sleph, J Ostrowski, J Lupisella, CS Ryan, X Liu, G Fernando, D Grimm, P Shipkova, R Zhang, R Garcia, J Zhu, A He, H Malone, R Martin, K Behnia, Z Wang, YC Barrett, RJ Garmise, L Yuan, J Zhang, MD Gandhi, P Wastall, T Li, S Du, L Salvador, R Mohan, GH Cantor, E Kick, J Lee, RJ Frost
Cell Metabolism 2016
Zinc alpha2 glycoprotein alleviates palmitic acid-induced intracellular lipid accumulation in hepatocytes
X Xiao, H Li, X Qi, Y Wang, C Xu, G Liu, G Wen, J Liu
Molecular and Cellular Endocrinology 2016
Arsenic trioxide suppresses liver X receptor β and enhances cholesteryl ester transfer protein expression without affecting the liver X receptor α in HepG2 cells
TJ Cheng, SW Lin, CW Chen, HR Guo, YJ Wang
Chemico-Biological Interactions 2016
Serum CETP status is independently associated with reduction rates in LDL-C in pitavastatin-treated diabetic patients and possible involvement of LXR in its association
A Shimada, H Kimura, K Oida, H Kanehara, Y Bando, S Sakamoto, T Wakasugi, T Saga, Y Ito, K Kamiyama, D Mikami, M Iwano, T Hirano, H Yoshida
Lipids in Health and Disease 2016
Serum CETP concentration is not associated with measures of body fat: The NEO study
LL Blauw, R Mutsert, HJ Lamb, A Roos, FR Rosendaal, JW Jukema, Y Wang, KW van Dijk, PC Rensen
Atherosclerosis 2016
Discovery of Highly Potent Liver X Receptor β Agonists
EK Kick, BB Busch, R Martin, WC Stevens, V Bollu, Y Xie, BC Boren, MC Nyman, MH Nanao, L Nguyen, A Plonowski, IG Schulman, G Yan, H Zhang, X Hou, MN Valente, R Narayanan, K Behnia, AD Rodrigues, B Brock, J Smalley, GH Cantor, J Lupisella, P Sleph, D Grimm, J Ostrowski, RR Wexler, T Kirchgessner, R Mohan
ACS Medicinal Chemistry Letters 2016
Liver X receptors at the intersection of lipid metabolism and atherogenesis
SD Lee, P Tontonoz
Atherosclerosis 2015
High-density lipoprotein synthesis and metabolism (Review)
L Zhou, C Li, L Gao, A Wang
Molecular medicine reports 2015
The potential of cholesteryl ester transfer protein as a therapeutic target
T Gautier, D Masson, L Lagrost
Expert Opinion on Therapeutic Targets 2015
Regulation of Hepatic Cholesteryl Ester Transfer Protein Expression and Reverse Cholesterol Transport by Inhibition of DNA Topoisomerase II
M Liu, Y Chen, L Zhang, Q Wang, X Ma, X Li, R Xiang, Y Zhu, S Qin, Y Yu, X Jiang, Y Duan, J Han
The Journal of biological chemistry 2015
Plasma cholesteryl ester transfer protein is predominantly derived from Kupffer cells: HEPATOLOGY, Vol. XX, No. X, 2015
Y Wang, S der Tuin, N Tjeerdema, AD van Dam, SS Rensen, T Hendrikx, JF Berbée, B Atanasovska, J Fu, M Hoekstra, S Bekkering, NP Riksen, WA Buurman, JW Greve, MH Hofker, R Shiri-Sverdlov, OC Meijer, JW Smit, LM Havekes, KW van Dijk, PC Rensen
Hepatology 2015
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
Liver X receptors in lipid metabolism: opportunities for drug discovery
C Hong, P Tontonoz
Nature Reviews Drug Discovery 2014
Coordinated Actions of FXR and LXR in Metabolism: From Pathogenesis to Pharmacological Targets for Type 2 Diabetes
L Ding, S Pang, Y Sun, Y Tian, L Yu, N Dang
International Journal of Endocrinology 2014
Pharmacological Characterization of a Novel Liver X Receptor Agonist with Partial LXR α Activity and a Favorable Window in Nonhuman Primates
TG Kirchgessner, R Martin, P Sleph, D Grimm, X Liu, J Lupisella, J Smalley, R Narayanan, Y Xie, J Ostrowski, G H., R Mohan, E Kick
The Journal of pharmacology and experimental therapeutics 2014
Elevated CETP activity during acute phase of myocardial infarction is independently associated with endothelial dysfunction and adverse clinical outcome
LS Carvalho, VW Virginio, NB Panzoldo, VN Figueiredo, SN Santos, RG Modolo, JM Andrade, JC Silva, W Nadruz-Junior, EC de Faria, AC Sposito
Atherosclerosis 2014
The LXR–Idol Axis Differentially Regulates Plasma LDL Levels in Primates and Mice
C Hong, SM Marshall, AL McDaniel, M Graham, JD Layne, L Cai, E Scotti, R Boyadjian, J Kim, BT Chamberlain, RK Tangirala, ME Jung, L Fong, R Lee, SG Young, RE Temel, P Tontonoz
Cell Metabolism 2014
Macrophage-Independent Regulation of Reverse Cholesterol Transport by Liver X Receptors
SR Breevoort, J Angdisen, IG Schulman
Arteriosclerosis, thrombosis, and vascular biology 2014
Fibrates and fish oil, but not corn oil, up-regulate the expression of the cholesteryl ester transfer protein (CETP) gene
HF Raposo, PR Patrício, MC Simões, HC Oliveira
The Journal of Nutritional Biochemistry 2014
Liver X Receptor: A Cardinal Target for Atherosclerosis and Beyond
M Parikh, K Patel, S Soni, T Gandhi
Journal of Atherosclerosis and Thrombosis 2014
The Medicinal Chemistry of Liver X Receptor (LXR) Modulators
CM Tice, PB Noto, KY Fan, L Zhuang, DS Lala, SB Singh
Journal of Medicinal Chemistry 2014
Farnesoid X receptor activation increases cholesteryl ester transfer protein expression in humans and transgenic mice
T Gautier, W Haan, J Grober, D Ye, MJ Bahr, T Claudel, N Nijstad, TJ van Berkel, LM Havekes, MP Manns, SM Willems, PC Hogendoorn, L Lagrost, F Kuipers, MV Eck, PC Rensen, UJ Tietge
Journal of lipid research 2013
Farnesoid X receptor activation increases cholesteryl ester transfer protein expression in humans and transgenic mice[S]
T Gautier, W Haan, J Grober, D Ye, MJ Bahr, T Claudel, N Nijstad, TJ van Berkel, LM Havekes, MP Manns, SM Willems, PC Hogendoorn, L Lagrost, F Kuipers, MV Eck, PC Rensen, UJ Tietge
Journal of lipid research 2013
Genome-wide landscape of liver X receptor chromatin binding and gene regulation in human macrophages
P Pehkonen, L Welter-Stahl, J Diwo, J Ryynänen, A Wienecke-Baldacchino, S Heikkinen, E Treuter, KR Steffensen, C Carlberg
BMC Genomics 2012
Nuclear Receptors in Nonalcoholic Fatty Liver Disease
JA López-Velázquez, LD Carrillo-Córdova, NC Chávez-Tapia, M Uribe, N Méndez-Sánchez
Journal of Lipids 2012
The Effects of Jiang-Zhi-Ning and Its Main Components on Cholesterol Metabolism
J Chen, H Zhao, X Ma, X Han, L Luo, L Wang, J Han, B Liu, W Wang
Evidence-based complementary and alternative medicine : eCAM 2012
Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR
AC Calkin, P Tontonoz
Nature Reviews Molecular Cell Biology 2012
The role of nuclear receptors in the kidney in obesity and metabolic syndrome
C Tovar-Palacio, N Torres, A Diaz-Villaseñor, AR Tovar
Genes & Nutrition 2012
Identification of Biological Markers of Liver X Receptor (LXR) Activation at the Cell Surface of Human Monocytes
C Rébé, R Filomenko, M Raveneau, A Chevriaux, M Ishibashi, L Lagrost, JL Junien, P Gambert, D Masson
PloS one 2012
Niacin reduces plasma CETP levels by diminishing liver macrophage content in CETP transgenic mice
Z Li, Y Wang, RJ van der Sluis, JW van der Hoorn, HM Princen, MV Eck, TJ van Berkel, PC Rensen, M Hoekstra
Biochemical Pharmacology 2012
Cholesterol and male fertility: What about orphans and adopted?
S Maqdasy, M Baptissart, A Vega, S Baron, JM Lobaccaro, DH Volle
Molecular and Cellular Endocrinology 2012
Atherosclerosis: lessons from LXR and the intestine
B Bonamassa, A Moschetta
Trends in Endocrinology & Metabolism 2012
SREBP: a novel therapeutic target
X Xiao, BL Song
Acta Biochimica et Biophysica Sinica 2012
Identification of Biological Markers of Liver X Receptor (LXR) Activation at the Cell Surface of Human Monocytes
C Rébé, R Filomenko, M Raveneau, A Chevriaux, M Ishibashi, L Lagrost, JL Junien, P Gambert, D Masson, CM Maya-Monteiro
PloS one 2012
Nuclear Hormone Receptors Enable Macrophages and Dendritic Cells to Sense Their Lipid Environment and Shape Their Immune Response
L Nagy, A Szanto, I Szatmari, L Széles
Physiological reviews 2012
Orphan Nuclear Receptors and the Regulation of Nutrient Metabolism: Understanding Obesity
MA Pearen, GE Muscat
Physiology (Bethesda, Md.) 2012
Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases plasma CETP and increases apolipoprotein AI levels without improving the cholesterol efflux properties of HDL
Y Wang, M Snel, JT Jonker, S Hammer, HJ Lamb, A Roos, AE Meinders, H Pijl, JA Romijn, JW Smit, IM Jazet, PC Rensen
Diabetes care 2011
Cholesteryl ester transfer protein: The controversial relation to atherosclerosis and emerging new biological roles
HC Oliveira, EC de Faria
IUBMB Life 2011
Plasma PLTP (phospholipid-transfer protein): an emerging role in ‘reverse lipopolysaccharide transport’ and innate immunity
T Gautier, L Lagrost
Biochemical Society Transactions 2011
Lipid-sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome
M Vacca, C Degirolamo, R Mariani-Costantini, G Palasciano, A Moschetta
Wiley Interdisciplinary Reviews: Systems Biology and Medicine 2011
Alzheimer's disease: Cholesterol a menace?
A Mathew, Y Yoshida, T Maekawa, DS Kumar
Brain Research Bulletin 2011
Pitavastatin Increases ABCA1 Expression by Dual Mechanisms: SREBP2-Driven Transcriptional Activation and PPARα-Dependent Protein Stabilization but Without Activating LXR in Rat Hepatoma McARH7777 Cells
T Maejima, T Sugano, H Yamazaki, Y Yoshinaka, T Doi, S Tanabe, T Nishimaki-Mogami
Journal of Pharmacological Sciences 2011
Synthetic LXR agonist inhibits the development of atherosclerosis in New Zealand White rabbits
S Honzumi, A Shima, A Hiroshima, T Koieyama, N Terasaka
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2011
Characterization of Paralichthys olivaceus peroxisome proliferator-activated receptor-α gene as a master regulator of flounder lipid metabolism
HK Cho, HJ Kong, HY Kim, JH Cheong
General and Comparative Endocrinology 2011
Nuclear Receptors as Drug Targets for Metabolic Disease
IG Schulman
Advanced Drug Delivery Reviews 2010
TNF-alpha decreases ABCA1 expression and attenuates HDL cholesterol efflux in the human intestinal cell line Caco-2
FJ Field, K Watt, SN Mathur
Journal of lipid research 2010
Effects of Liver × receptor agonist treatment on signal transduction pathways in acute lung inflammation
C Crisafulli, E Mazzon, I Paterniti, M Galuppo, P Bramanti, S Cuzzocrea
Respiratory Research 2010
Coronary heart disease: Significance of liver X receptor α genomics
VP Dave, D Kaul
World journal of cardiology 2010
LXRα regulates human CETP expression in vitro and in transgenic mice
S Honzumi, A Shima, A Hiroshima, T Koieyama, N Ubukata, N Terasaka
Atherosclerosis 2010
Differential effects of activation of liver X receptor on plasma lipid homeostasis in wild-type and lipoprotein clearance-deficient mice
D Peng, RA Hiipakka, JT Xie, CA Reardon, GS Getz, S Liao
Atherosclerosis 2010
Increased expression of RXRα in dementia: an early harbinger for the cholesterol dyshomeostasis?
A Akram, J Schmeidler, P Katsel, PR Hof, V Haroutunian
Molecular Neurodegeneration 2010
Pioglitazone decreases plasma cholesteryl ester transfer protein mass, associated with a decrease in hepatic triglyceride content, in patients with type 2 diabetes
JT Jonker, Y Wang, W Haan, M Diamant, LJ Rijzewijk, RW van der Meer, HJ Lamb, JT Tamsma, A Roos, JA Romijn, PC Rensen, JW Smit
Diabetes care 2010
Cholesteryl Ester Transfer Protein Inhibition in Cardiovascular Risk Management: Ongoing Trials will End the Confusion
PJ Kappelle, AV Tol, BH Wolffenbuttel, RP Dullaart
Cardiovascular Therapeutics 2010
The liver X receptor: Control of cellular lipid homeostasis and beyond
MH Oosterveer, A Grefhorst, AK Groen, F Kuipers
Progress in Lipid Research 2010
Regulation of cholesterol homeostasis by liver X receptors
YW Hu, L Zheng, Q Wang
Clinica Chimica Acta 2010
Vitamins & Hormones
KJ Hare, FK Knop
Vitamins & Hormones 2010
The HDL Handbook
NJ Hime
The HDL Handbook 2010
TNF-α decreases ABCA1 expression and attenuates HDL cholesterol efflux in the human intestinal cell line Caco-2
FJ Field, K Watt, SN Mathur
Journal of lipid research 2010
Coronary heart disease: Significance of liver X receptor α genomics
VP Dave
World journal of cardiology 2010
Minireview: Liver X Receptor β: Emerging Roles in Physiology and Diseases
C Gabbi, M Warner, JÅ Gustafsson
Molecular Endocrinology 2009
Liver X Receptors as Therapeutic Targets for Managing Cholesterol: Implications for Atherosclerosis and Other Inflammatory Conditions
Y Zhang, JF Chan, CL Cummins
Clinical Lipidology 2009
The role of plasma lipid transfer proteins in lipoprotein metabolism and atherogenesis
D Masson, XC Jiang, L Lagrost, AR Tall
Journal of lipid research 2009
Latest Insights Into High-Density Lipoprotein Functions
H Noto
The Endocrinologist 2009
Molecular cloning of hamster lipid transfer inhibitor protein (apolipoprotein F) and regulation of its expression by hyperlipidemia
L Izem, RE Morton
Journal of lipid research 2009
Ciprofibrate increases cholesteryl ester transfer protein gene expression and the indirect reverse cholesterol transport to the liver
EJ Bighetti, PR Patrício, AC Casquero, JA Berti, HC Oliveira
Lipids in Health and Disease 2009
The discovery of tertiary-amine LXR agonists with potent cholesterol efflux activity in macrophages
JP Marino, LS Kallander, C Ma, HJ Oh, D Lee, DE Gaitanopoulos, JA Krawiec, DJ Parks, CL Webb, K Ziegler, M Jaye, SK Thompson
Bioorganic & Medicinal Chemistry Letters 2009
The conjugated linoleic acid isomer trans-9,trans-11 is a dietary occurring agonist of liver X receptor α
J Ecker, G Liebisch, W Patsch, G Schmitz
Biochemical and Biophysical Research Communications 2009
Serum cholesterol and expression of ApoAI, LXRβ and SREBP2 in vitamin D receptor knock-out mice
JH Wang, T Keisala, T Solakivi, A Minasyan, AV Kalueff, P Tuohimaa
The Journal of Steroid Biochemistry and Molecular Biology 2009
Liver X receptor modulators: Effects on lipid metabolism and potential use in the treatment of atherosclerosis
C Fiévet, B Staels
Biochemical Pharmacology 2009
Safety, Pharmacokinetics, and Pharmacodynamics of Single Doses of LXR-623, a Novel Liver X-Receptor Agonist, in Healthy Participants
A Katz, C Udata, E Ott, L Hickey, ME Burczynski, P Burghart, O Vesterqvist, X Meng
The Journal of Clinical Pharmacology 2009
Bexarotene Induces Dyslipidemia by Increased Very Low-Density Lipoprotein Production and Cholesteryl Ester Transfer Protein-Mediated Reduction of High-Density Lipoprotein
J de Vries-van der Weij, W de Haan, L Hu, M Kuif, HL Oei, JW van der Hoorn, LM Havekes, HM Princen, JA Romijn, JW Smit, PC Rensen
Endocrinology 2009
Transport−Metabolism Interplay: LXRα-Mediated Induction of Human ABC Transporter ABCC2 (cMOAT/MRP2) in HepG2 Cells
T Adachi, H Nakagawa, Y Hagiya, T Yasuoka, T Ishikawa
Molecular Pharmaceutics 2009
Liver x receptor: a novel therapeutic target
MB Patel, NA Oza, IS Anand, SS Deshpande, CN Patel
Indian journal of pharmaceutical sciences 2008
Origins of intestinal ABCA1-mediated HDL-cholesterol
FJ Field, K Watt, SN Mathur
Journal of lipid research 2008
Fluctuation of lipoprotein metabolism linked with bile acid-activated liver nuclear receptors in Alagille syndrome
H Nagasaka, T Miida, K Hirano, A Ota, K Murayama, T Yorifuji, K Kobayashi, T Takatani, H Tsukahara, SP Hui, M Takayanagi, H Chiba
Atherosclerosis 2008
Macronutrients and obesity: views, news and reviews
L Madsen, B Liaset, K Kristiansen
Future Lipidology 2008
Peroxisome Proliferator-Activated Receptor α Agonists Regulate Cholesterol Ester Transfer Protein
TP Beyer, Y Chen, RK Porter, D Lu, RJ Schmidt, NB Mantlo, RJ Konrad, G Cao
Lipids 2008
Transcriptional regulation of the humanCYP46A1brain-specific expression by Sp transcription factors
I Milagre, MJ Nunes, MJ Gama, RF Silva, JM Pascussi, MC Lechner, E Rodrigues
Journal of Neurochemistry 2008
CETP activity variation in mice does not affect two major HDL antiatherogenic properties: Macrophage-specific reverse cholesterol transport and LDL antioxidant protection
N Rotllan, L Calpe-Berdiel, A Guillaumet-Adkins, S Süren-Castillo, F Blanco-Vaca, JC Escolà-Gil
Atherosclerosis 2008
Common variation in theCETPgene and the implications for cardiovascular disease and its treatment: an updated analysis
RP Dullaart, WJ Sluiter
Pharmacogenomics 2008
Renin–angiotensin–aldosterone responsiveness to low sodium and blood pressure reactivity to angiotensin-II are unrelated to cholesteryl ester transfer protein mass in healthy subjects
JA Krikken, GM Dallinga-Thie, G Navis, RP Dullaart
Expert Opinion on Therapeutic Targets 2008
Selective partial agonism of liver X receptor alpha is related to differential corepressor recruitment
CA Phelan, JM Weaver, DJ Steger, S Joshi, JT Maslany, JL Collins, WJ Zuercher, TM Willson, M Walker, M Jaye, MA Lazar
Molecular Endocrinology 2008
Physiogenomic comparison of human fat loss in response to diets restrictive of carbohydrate or fat
RL Seip, JS Volek, A Windemuth, M Kocherla, ML Fernandez, WJ Kraemer, G Ruaño
Nutrition & Metabolism 2008
Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice
W Haan, CC van der Hoogt, M Westerterp, M Hoekstra, GM Dallinga-Thie, HM Princen, JA Romijn, JW Jukema, LM Havekes, PC Rensen
Atherosclerosis 2008
Liver X Receptors (LXR) as Therapeutic Targets in Dyslipidemia
J Bełtowski
Cardiovascular Therapeutics 2008
Association between liver X receptor α gene polymorphisms and risk of metabolic syndrome in French populations
V Legry, D Cottel, J Ferrières, G Chinetti, T Deroide, B Staels, P Amouyel, A Meirhaeghe
International Journal of Obesity 2008
Liver X receptor agonist downregulates hepatic apoM expression in vivo and in vitro
X Zhang, Z Zhu, G Luo, L Zheng, P Nilsson-Ehle, N Xu
Biochemical and Biophysical Research Communications 2008
Atherogenic lipoprotein particle size and concentrations and the effect of pravastatin in children with familial hypercholesterolemia
A der Graaf, J Rodenburg, MN Vissers, BA Hutten, A Wiegman, MD Trip, ES Stroes, FA Wijburg, JD Otvos, JJ Kastelein
The Journal of Pediatrics 2008
Origins of intestinal ABCA1-mediated HDL-cholesterol
FJ Field, K Watt, SN Mathur
Journal of lipid research 2008
The role of plasma lipid transfer proteins in lipoprotein metabolism and atherogenesis
D Masson, XC Jiang, L Lagrost, AR Tall
Journal of lipid research 2008
Molecular cloning of hamster lipid transfer inhibitor protein (apolipoprotein F) and regulation of its expression by hyperlipidemia
L Izem, RE Morton
Journal of lipid research 2008
Atherosclerosis and Oxidant Stress
JL Holtzman
2008
GW3965, a synthetic liver X receptor (LXR) agonist, reduces angiotensin II-mediated pressor responses in Sprague-Dawley rats
CE Leik, NL Carson, JK Hennan, MD Basso, QY Liu, DL Crandall, P Nambi
British Journal of Pharmacology 2007
Comprehensive Medicinal Chemistry II
E Littler, XX Zhou
Comprehensive Medicinal Chemistry II 2007
A Key Role for Orphan Nuclear Receptor Liver Receptor Homologue-1 in Activation of Fatty Acid Synthase Promoter by Liver X Receptor
KE Matsukuma, L Wang, MK Bennett, TF Osborne
The Journal of biological chemistry 2007
Fenofibrate increases HDL-cholesterol by reducing cholesteryl ester transfer protein expression
CC van der Hoogt, W Haan, M Westerterp, M Hoekstra, GM Dallinga-Thie, JA Romijn, HM Princen, JW Jukema, LM Havekes, PC Rensen
Journal of lipid research 2007
High‐Density Lipoproteins: From Basic Biology to Clinical Aspects
CJ Fielding
2007
Liver X receptors as integrators of metabolic and inflammatory signaling
N Zelcer, P Tontonoz
Journal of Clinical Investigation 2006
International Union of Pharmacology. LXII. The NR1H and NR1I Receptors: Constitutive Androstane Receptor, Pregnene X Receptor, Farnesoid X Receptor α, Farnesoid X Receptor β, Liver X Receptor α, Liver X Receptor β, and Vitamin D Receptor
DD Moore, S Kato, W Xie, DJ Mangelsdorf, DR Schmidt, R Xiao, SA Kliewer
Pharmacological reviews 2006
A role for CETP TaqIB polymorphism in determining susceptibility to atrial fibrillation: a nested case control study
FW Asselbergs, JH Moore, MP van Berg, EB Rimm, RA de Boer, RP Dullaart, G Navis, WH van Gilst
BMC Medical Genetics 2006
REGULATION OF HEPATIC CHOLESTEROL METABOLISM IN CETP+/?/LDLr+/?MICE BY CHOLESTEROL FEEDING AND BY DRUGS (CHOLESTYRAMINE AND LOVASTATIN) THAT LOWER PLASMA CHOLESTEROL
LM Harada, AJ Carrilho, HC Oliveira, ER Nakandakare, EC Quintão
Clinical and Experimental Pharmacology and Physiology 2006
Plasma lipid transfer proteins
XC Jiang, HW Zhou
Current Opinion in Lipidology 2006
LXRS AND FXR: The Yin and Yang of Cholesterol and Fat Metabolism
NY Kalaany, DJ Mangelsdorf
Annual Review of Physiology 2006
Nuclear receptors as drug targets in metabolic diseases: new approaches to therapy
JF Tobin, LP Freedman
Trends in Endocrinology & Metabolism 2006
Liver X receptors: new drug targets to treat Type 2 diabetes?
KR Steffensen, JÅ Gustafsson
Future Lipidology 2006
SYNERGISTIC EFFECT OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR-?? AND LIVER X RECEPTOR-?? IN THE REGULATION OF INFLAMMATION IN MACROPHAGES
G Piraino, JA Cook, M O'Connor, PW Hake, TJ Burroughs, D Teti, B Zingarelli
Shock 2006
¿Existen aún nuevas dianas terapéuticas en la arteriosclerosis? LXR y FXR
J Martínez-González, L Badimón
Clínica e Investigación en Arteriosclerosis 2006
Correction of Apolipoprotein A-I-mediated Lipid Efflux and High Density Lipoprotein Particle Formation in Human Niemann-Pick Type C Disease Fibroblasts
E Boadu, HY Choi, DW Lee, EI Waddington, T Chan, B Asztalos, JE Vance, A Chan, G Castro, GA Francis
The Journal of biological chemistry 2006
Phosphorylation of the Hinge Domain of the Nuclear Hormone Receptor LRH-1 Stimulates Transactivation
YK Lee, YH Choi, S Chua, YJ Park, DD Moore
The Journal of biological chemistry 2006
A 15-ketosterol is a liver X receptor ligand that suppresses sterol-responsive element binding protein-2 activity
RJ Schmidt, JV Ficorilli, Y Zhang, KS Bramlett, TP Beyer, K Borchert, MS Dowless, KA Houck, TP Burris, PI Eacho, G Liang, L Guo, WK Wilson, LF Michael, G Cao
Journal of lipid research 2006
Coordinated control of bile acids and lipogenesis through FXR-dependent regulation of fatty acid synthase
KE Matsukuma, MK Bennett, J Huang, L Wang, G Gil, TF Osborne
Journal of lipid research 2006
Reduced Fat Mass in Rats Fed a High Oleic Acid–Rich Safflower Oil Diet Is Associated with Changes in Expression of Hepatic PPARα and Adipose SREBP-1c–Regulated Genes1,2
SC Hsu, C Huang
The Journal of nutrition 2006
Transcriptional regulatory networks in lipid metabolism control ABCA1 expression
G Schmitz, T Langmann
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2005
Hepatic Peroxisomal Fatty Acid β-Oxidation Is Regulated by Liver X Receptor α
T Hu, P Foxworthy, A Siesky, JV Ficorilli, H Gao, S Li, M Christe, T Ryan, G Cao, P Eacho, MD Michael, LF Michael
Endocrinology 2005
LXR is crucial in lipid metabolism
SM Ulven, KT Dalen, JÅ Gustafsson, HI Nebb
Prostaglandins, Leukotrienes and Essential Fatty Acids 2005
Retinoid X Receptor Heterodimers in the Metabolic Syndrome
AI Shulman, DJ Mangelsdorf
New England Journal of Medicine 2005
Skin Barrier: Epidermal Liposensors
M Schmuth
Skin Barrier 2005
LXR: A nuclear receptor target for cardiovascular disease?
MN Bradley, P Tontonoz
Drug Discovery Today: Therapeutic Strategies 2005
Synthetic LXR agonists increase LDL in CETP species
PH Groot, NJ Pearce, JW Yates, C Stocker, C Sauermelch, CP Doe, RN Willette, A Olzinski, T Peters, D d'Epagnier, KO Morasco, JA Krawiec, CL Webb, K Aravindhan, B Jucker, M Burgert, C Ma, JP Marino, JL Collins, CH Macphee, SK Thompson, M Jaye
Journal of lipid research 2005
Identification and characterization of two alternatively spliced transcript variants of human liver X receptor alpha
M Chen, S Beaven, P Tontonoz
Journal of lipid research 2005
Lack of stimulation of cholesteryl ester transfer protein by cholesterol in the presence of a high-fat diet
SK Cheema, A Agarwal-Mawal, CM Murray, S Tucker
Journal of lipid research 2005
Regulation of the Aldo-Keto Reductase Gene akr1b7 by the Nuclear Oxysterol Receptor LXRα (Liver X Receptor-α) in the Mouse Intestine: Putative Role of LXRs in Lipid Detoxification Processes
DH Volle, JJ Repa, A Mazur, CL Cummins, P Val, J Henry-Berger, F Caira, G Veyssiere, DJ Mangelsdorf, JM Lobaccaro
Molecular Endocrinology 2004
Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia
WL Goff, M Guerin, MJ Chapman
Pharmacology & Therapeutics 2004
A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes
Y Liang, S Lin, TP Beyer, Y Zhang, X Wu, KR Bales, RB DeMattos, PC May, SD Li, XC Jiang, PI Eacho, G Cao, SM Paul
Journal of Neurochemistry 2004
Molecular regulation of SREBP function: the Insig-SCAP connection and isoform-specific modulation of lipid synthesis
R McPherson, A Gauthier
Biochemistry and Cell Biology 2004
Expression of the liver X receptor ? and ? in embryonic and adult mice
JS Annicotte, K Schoonjans, J Auwerx
The Anatomical Record 2004
Liver X receptor agonists as a treatment for atherosclerosis
DJ Bennett, AJ Cooke, AS Edwards, E Moir, PC Ray
Expert Opinion on Therapeutic Patents 2004
Cholesteryl ester transfer protein promoter single-nucleotide polymorphisms in Sp1-binding sites affect transcription and are associated with high-density lipoprotein cholesterol
JF Thompson, DB Lloyd, ME Lira, PM Milos
Clinical Genetics 2004
Les oxystérols : métabolisme, rôles biologiques et pathologies associées
M Souidi, S Dubrac, M Parquet, DH Volle, JM Lobaccaro, D Mathé, O Combes, P Scanff, C Lutton, J Aigueperse
Gastroentérologie Clinique et Biologique 2004
Oxysterols and oxysterol binding proteins: role in lipid metabolism and atherosclerosis
VM Olkkonen, M Lehto
Annals of Medicine 2004
Apolipoprotein CI overexpression is not a relevant strategy to block cholesteryl ester transfer protein (CETP) activity in CETP transgenic mice
T GAUTIER, D MASSON, MC JONG, JP BARROS, L DUVERNEUIL, NL GUERN, V DECKERT, L DUMONT, A BATAILLE, Z ZAK, XC JIANG, LM HAVEKES, L LAGROST
Biochemical Journal 2004
Coadministration of a Liver X Receptor Agonist and a Peroxisome Proliferator Activator Receptor-α Agonist in Mice: Effects of Nuclear Receptor Interplay on High-Density Lipoprotein and Triglyceride Metabolism in Vivo
TP Beyer, RJ Schmidt, P Foxworthy, Y Zhang, J Dai, WR Bensch, RF Kauffman, H Gao, TP Ryan, XC Jiang, SK Karathanasis, PI Eacho, G Cao
The Journal of pharmacology and experimental therapeutics 2004
The Nuclear Oxysterol Receptor LXRα Is Expressed in the Normal Human Breast and in Breast Cancer
DM Vigushin, Y Dong, L Inman, N Peyvandi, JP Alao, C Sun, S Ali, EJ Niesor, CL Bentzen, RC Coombes
Medical Oncology 2004
Potentiation of liver X receptor transcriptional activity by peroxisome-proliferator-activated receptor gamma co-activator 1 alpha
H Oberkofler, E Schraml, F Krempler, W Patsch
Biochemical Journal 2003
Liver X receptor signaling pathways in cardiovascular disease
P Tontonoz, DJ Mangelsdorf
Molecular Endocrinology 2003
An evolutionary approach for identifying potential transcription factor binding sites: the renin gene as an example
KR Steffensen, JA Gustafsson
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2003
An evolutionary approach for identifying potential transcription factor binding sites: the renin gene as an example
KR Steffensen, JA Gustafsson
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2003
HDL: The Metabolism, Function, and Therapeutic Importance
M Wang, MR Briggs
Chemical Reviews 2003
Oxysterol and 9-cis-retinoic acid stimulate the group IIA secretory phospholipase A2 gene in rat smooth-muscle cells
V Antonio, B Janvier, A Brouillet, M Andreani, M Raymondjean
Biochemical Journal 2003
NUCLEARRECEPTORS AND THECONTROL OFMETABOLISM
GA Francis, E Fayard, F Picard, J Auwerx
Annual Review of Physiology 2003
Cholesterol-receptor-mediated genomics in health and disease
D Kaul
Trends in Molecular Medicine 2003
Atheroprotective Effects of High-Density Lipoproteins
G Assmann, JR Nofer
Annual Review of Medicine 2003
Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue
BA Laffitte, LC Chao, J Li, R Walczak, S Hummasti, SB Joseph, A Castrillo, DC Wilpitz, DJ Mangelsdorf, JL Collins, E Saez, P Tontonoz
Proceedings of the National Academy of Sciences 2003
Effects of dietary 27-hydroxycholesterol on cholesterol metabolism and bile acid biosynthesis in the hamster
M Souidi, S Dubrac, M Parquet, F Milliat, J Férézou, C Sérougne, C Loison, M Riottot, N Boudem, T Bécue, C Lutton
Canadian Journal of Physiology and Pharmacology 2003
Expression, regulation, and activity of ABCA1 in human cell lines
M Denis, R Bissonnette, B Haidar, L Krimbou, M Bouvier, J Genest
Molecular Genetics and Metabolism 2003
Temporal gene expression changes during adipogenesis in human mesenchymal stem cells
T Nakamura, S Shiojima, Y Hirai, T Iwama, N Tsuruzoe, A Hirasawa, S Katsuma, G Tsujimoto
Biochemical and Biophysical Research Communications 2003
Syntheses of oxysterol receptors’(LXRs) ligands
X Zhou, H Zhen, W Zhou
Chinese Science Bulletin 2003
Molecular determinants of LXRα agonism
M Wang, J Thomas, TP Burris, J Schkeryantz, LF Michael
Journal of Molecular Graphics and Modelling 2003
N UCLEAR R ECEPTORS AND THE C ONTROL OF M ETABOLISM
GA Francis, E Fayard, F Picard, J Auwerx
Annual Review of Physiology 2003
Pharmacological evidence for a role of liver X receptors in atheroprotection
PT Kovanen, MO Pentikäinen
FEBS Letters 2003
An evolutionary approach for identifying potential transcription factor binding sites: the renin gene as an example
KR Steffensen, JA Gustafsson
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2003
Lipids and Atherosclerosis Annual 2003
I Schulman, R Heyman
Lipids and Atherosclerosis Annual 2003 2003
Los receptores nucleares como nuevas dianas terapéuticas para un manejo integral de las dislipemias
A Rigotti
Clínica e Investigación en Arteriosclerosis 2003
Enlargement of High Density Lipoprotein in Mice via Liver X Receptor Activation Requires Apolipoprotein E and Is Abolished by Cholesteryl Ester Transfer Protein Expression
XC Jiang, TP Beyer, Z Li, J Liu, W Quan, RJ Schmidt, Y Zhang, WR Bensch, PI Eacho, G Cao
The Journal of biological chemistry 2003
Expression of the Insulin-responsive Glucose Transporter GLUT4 in Adipocytes Is Dependent on Liver X Receptor α
KT Dalen, SM Ulven, K Bamberg, JÅ Gustafsson, HI Nebb
The Journal of biological chemistry 2003
Hypertriglyceridemia in Lecithin-cholesterol Acyltransferase-deficient Mice Is Associated with Hepatic Overproduction of Triglycerides, Increased Lipogenesis, and Improved Glucose Tolerance
DS Ng, C Xie, GF Maguire, X Zhu, F Ugwu, E Lam, PW Connelly
The Journal of biological chemistry 2003
Regulation of ABCA1 expression and cholesterol efflux during adipose differentiation of 3T3-L1 cells
SL Lay, C Robichon, XL Liepvre, G Dagher, P Ferre, I Dugail
Journal of lipid research 2003
Regulation of human CETP gene expression: role of SP1 and SP3 transcription factors at promoter sites −690, −629, and −37
WL Goff, M Guerin, L Petit, MJ Chapman, J Thillet
Journal of lipid research 2003
Cholesteryl ester transfer protein modulates the effect of liver X receptor agonists on cholesterol transport and excretion in the mouse
D Masson, B Staels, T Gautier, C Desrumaux, A Athias, NL Guern, M Schneider, Z Zak, L Dumont, V Deckert, A Tall, XC Jiang, L Lagrost
Journal of lipid research 2003
Cholesteryl ester transfer protein expression is down-regulated in hyperinsulinemic transgenic mice
JA Berti, AC Casquero, PR Patrício, EJ Bighetti, EM Carneiro, AC Boschero, HC Oliveira
Journal of lipid research 2003
A CYP7A promoter binding factor site and Alu repeat in the distal promoter region are implicated in regulation of human CETP gene expression
WL Goff, M Guerin, MJ Chapman, J Thillet
Journal of lipid research 2003
Activating Signal Cointegrator 2 Required for Liver Lipid Metabolism Mediated by Liver X Receptors in Mice
SW Kim, K Park, E Kwak, E Choi, S Lee, J Ham, H Kang, JM Kim, SY Hwang, YY Kong, K Lee, JW Lee
Molecular and cellular biology 2003
Liver X receptors and the control of cholesterol homeostasis: potential therapeutic targets for the treatment of atherosclerosis
LJ Millatt, V Bocher, JC Fruchart, B Staels
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2003
Frontiers in Cardiovascular Health
NS Dhalla, A Chockalingam, HI Berkowitz, PK Singal
2003
A Natural Product Ligand of the Oxysterol Receptor, Liver X Receptor
KS Bramlett, KA Houck, KM Borchert, MS Dowless, P Kulanthaivel, Y Zhang, TP Beyer, R Schmidt, JS Thomas, LF Michael, R Barr, C Montrose, PI Eacho, G Cao, TP Burris
The Journal of pharmacology and experimental therapeutics 2003
Liver X Receptors Interact with Corepressors to Regulate Gene Expression
X Hu, S Li, J Wu, C Xia, DS Lala
Molecular Endocrinology 2003
A Novel Liver X Receptor Agonist Establishes Species Differences in the Regulation of Cholesterol 7α-Hydroxylase (CYP7a)
JG Menke, KL Macnaul, NS Hayes, J Baffic, YS Chao, A Elbrecht, LJ Kelly, MH Lam, A Schmidt, S Sahoo, J Wang, SD Wright, P Xin, G Zhou, DE Moller, CP Sparrow
Endocrinology 2002
Bile Acid Regulation of Gene Expression: Roles of Nuclear Hormone Receptors
JY Chiang
Endocrine reviews 2002
Synthetic LXR ligand inhibits the development of atherosclerosis in mice
SB Joseph, E McKilligin, L Pei, MA Watson, AR Collins, BA Laffitte, M Chen, G Noh, J Goodman, GN Hagger, J Tran, TK Tippin, X Wang, AJ Lusis, WA Hsueh, RE Law, JL Collins, TM Willson, P Tontonoz
Proceedings of the National Academy of Sciences 2002
Wiley Encyclopedia of Molecular Medicine
WT Morgan
Wiley Encyclopedia of Molecular Medicine 2002
Molecular basis of cholesterol homeostasis: lessons from Tangier disease and ABCA1
JF Oram
Trends in Molecular Medicine 2002
Microarray analyses during adipogenesis: understanding the effects of Wnt signaling on adipogenesis and the roles of liver X receptor alpha in adipocyte metabolism
SE Ross, RL Erickson, I Gerin, PM DeRose, L Bajnok, KA Longo, DE Misek, R Kuick, SM Hanash, KB Atkins, SM Andresen, HI Nebb, L Madsen, K Kristiansen, OA MacDougald
Molecular and cellular biology 2002
Oxysterol-activated LXR/RXR induces SR-BI-promoter activity in hepatoma cells and preadipocytes
L Malerød, LK Juvet, A Hanssen-Bauer, W Eskild, T Berg
Biochemical and Biophysical Research Communications 2002
Liver X receptor and retinoic X receptor mediated ABCA1 regulation and cholesterol efflux in macrophage cells—messenger RNA measured by branched DNA technology
Y Zhang, TP Beyer, KS Bramlett, S Yao, TP Burris, RJ Schmidt, PI Eacho, G Cao
Molecular Genetics and Metabolism 2002
Genetic disorders associated with ATP binding cassette cholesterol transporters
TP Burris, PI Eacho, G Cao
Molecular Genetics and Metabolism 2002
Oxysterols in human circulation: which role do they have?
I Björkhem, S Meaney, U Diczfalusy
Current Opinion in Lipidology 2002
Genetics and molecular biology: apolipoprotein E - from plasma lipids to plaque stability
S Lorkowski, P Cullen
Current Opinion in Lipidology 2002
Oxysterol Stimulation of Epidermal Differentiation is Mediated by Liver X Receptor-beta in Murine Epidermis
LG Komuves, M Schmuth, AJ Fowler, PM Elias, K Hanley, MQ Man, AH Moser, JM Lobaccaro, ML Williams, DJ Mangelsdorf, KR Feingold
Journal of Investigative Dermatology 2002
A Short and Highly Stereoselective Synthesis of Cerebrosterol
DH Zhang, XD Zhou, WS Zhou
Chinese Journal of Chemistry 2002
Nuclear receptor regulation of hepatic function
SJ Karpen
Journal of Hepatology 2002
The liver X receptor gene team: Potential new players in atherosclerosis
JJ Repa, DJ Mangelsdorf
Nature Medicine 2002
Novel roles of liver X receptors exposed by gene expression profiling in liver and adipose tissue
TM Stulnig, KR Steffensen, H Gao, M Reimers, K Dahlman-Wright, GU Schuster, JA Gustafsson
Molecular pharmacology 2002
Liver X Receptors Downregulate 11 -Hydroxysteroid Dehydrogenase Type 1 Expression and Activity
TM Stulnig, U Oppermann, KR Steffensen, GU Schuster, JA Gustafsson
Diabetes 2002
Phospholipid Transfer Protein Is Regulated by Liver X Receptors in Vivo
G Cao, TP Beyer, XP Yang, RJ Schmidt, Y Zhang, WR Bensch, RF Kauffman, H Gao, TP Ryan, Y Liang, PI Eacho, XC Jiang
The Journal of biological chemistry 2002
Antidiabetic Action of a Liver X Receptor Agonist Mediated By Inhibition of Hepatic Gluconeogenesis
G Cao, Y Liang, CL Broderick, BA Oldham, TP Beyer, RJ Schmidt, Y Zhang, KR Stayrook, C Suen, KA Otto, AR Miller, J Dai, P Foxworthy, H Gao, TP Ryan, XC Jiang, TP Burris, PI Eacho, GJ Etgen
The Journal of biological chemistry 2002
A Chemical Switch Regulates Fibrate Specificity for Peroxisome Proliferator-activated Receptor α (PPARα) Versus Liver X Receptor
J Thomas, KS Bramlett, C Montrose, P Foxworthy, PI Eacho, D McCann, G Cao, A Kiefer, J McCowan, K Yu, T Grese, WW Chin, TP Burris, LF Michael
The Journal of biological chemistry 2002
LXR/RXR activation enhances basolateral efflux of cholesterol in CaCo-2 cells
S Murthy, E Born, SN Mathur, FJ Field
Journal of lipid research 2002
The Small Heterodimer Partner Interacts with the Liver X Receptor α and Represses Its Transcriptional Activity
C Brendel, K Schoonjans, OA Botrugno, E Treuter, J Auwerx
Molecular Endocrinology 2002
Regulation of Cholesterol Homeostasis by the Liver X Receptors in the Central Nervous System
KD Whitney, MA Watson, JL Collins, WG Benson, TM Stone, MJ Numerick, TK Tippin, JG Wilson, DA Winegar, SA Kliewer
Molecular Endocrinology 2002
BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis
PA Edwards, HR Kast, AM Anisfeld
Journal of lipid research 2002
Xol INXS: role of the liver X and the farnesol X receptors
E Fayard, K Schoonjans, J Auwerx
Current Opinion in Lipidology 2001
Novel approaches to treating cardiovascular disease: lessons from Tangier disease
JF Oram
Expert Opinion on Investigational Drugs 2001
Expression of the ATP-Binding Cassette Transporter Gene ABCG1 (ABC8) in Tangier Disease
S Lorkowski, M Kratz, C Wenner, R Schmidt, B Weitkamp, M Fobker, J Reinhardt, J Rauterberg, EA Galinski, P Cullen
Biochemical and Biophysical Research Communications 2001
Hypolipidemic effects of selective liver X receptor alpha agonists
C Song, S Liao
Steroids 2001
Auto-oxidized cholesterol sulfates are antagonistic ligands of liver X receptors: implications for the development and treatment of atherosclerosis
C Song, RA Hiipakka, S Liao
Steroids 2001
Regulation of cholesterol 7α-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRα)
JY Chiang, R Kimmel, D Stroup
Gene 2001
A new highly stereoselective synthesis of cerebrosterol, an agonist of the nuclear receptor LXRs
XD Zhou, WS Zhou
Tetrahedron 2001
Glucose Regulates the Transcription of Human Genes Relevant to HDL Metabolism: Responsive Elements for Peroxisome Proliferator-Activated Receptor Are Involved in the Regulation of Phospholipid Transfer Protein
AY Tu, JJ Albers
Diabetes 2001
Characterization of the Human ABCG1 Gene: LIVER X RECEPTOR ACTIVATES AN INTERNAL PROMOTER THAT PRODUCES A NOVEL TRANSCRIPT ENCODING AN ALTERNATIVE FORM OF THE PROTEIN
MA Kennedy, A Venkateswaran, PT Tarr, I Xenarios, J Kudoh, N Shimizu, PA Edwards
The Journal of biological chemistry 2001
27-Hydroxycholesterol Is an Endogenous Ligand for Liver X Receptor in Cholesterol-loaded Cells
X Fu, JG Menke, Y Chen, G Zhou, KL MacNaul, SD Wright, CP Sparrow, EG Lund
The Journal of biological chemistry 2001
The Orphan Nuclear Receptor LRH-1 Potentiates the Sterol-mediated Induction of the Human CETP Gene by Liver X Receptor
Y Luo, C Liang, AR Tall
The Journal of biological chemistry 2001
Orphan Nuclear Receptors as eLiXiRs and FiXeRs of Sterol Metabolism
TT Lu, JJ Repa, DJ Mangelsdorf
The Journal of biological chemistry 2001
Polyunsaturated Fatty Acids Suppress Sterol Regulatory Element-binding Protein 1c Promoter Activity by Inhibition of Liver X Receptor (LXR) Binding to LXR Response Elements
T Yoshikawa, H Shimano, N Yahagi, T Ide, M Amemiya-Kudo, T Matsuzaka, M Nakakuki, S Tomita, H Okazaki, Y Tamura, Y Iizuka, K Ohashi, A Takahashi, H Sone, J Osuga, T Gotoda, S Ishibashi, N Yamada
The Journal of biological chemistry 2001
Regulation of Lipoprotein Lipase by the Oxysterol Receptors, LXRα and LXRβ
Y Zhang, JJ Repa, K Gauthier, DJ Mangelsdorf
The Journal of biological chemistry 2001
Cholesteryl Ester Transfer Protein Biosynthesis and Cellular Cholesterol Homeostasis Are Tightly Interconnected
L Izem, RE Morton
The Journal of biological chemistry 2001
Identification of Liver X Receptor-Retinoid X Receptor as an Activator of the Sterol Regulatory Element-Binding Protein 1c Gene Promoter
T Yoshikawa, H Shimano, M Amemiya-Kudo, N Yahagi, AH Hasty, T Matsuzaka, H Okazaki, Y Tamura, Y Iizuka, K Ohashi, JI Osuga, K Harada, T Gotoda, S Kimura, S Ishibashi, N Yamada
Molecular and cellular biology 2001
High Density Lipoproteins and Arteriosclerosis: Role of Cholesterol Efflux and Reverse Cholesterol Transport
A von Eckardstein, JR Nofer, G Assmann
Arteriosclerosis, thrombosis, and vascular biology 2001
Point Mutation (−69 G→A) in the Promoter Region of Cholesteryl Ester Transfer Protein Gene in Japanese Hyperalphalipoproteinemic Subjects
M Nagano, S Yamashita, K Hirano, T Kujiraoka, M Ito, Y Sagehashi, H Hattori, N Nakajima, T Maruyama, N Sakai, T Egashira, Y Matsuzawa
Arteriosclerosis, thrombosis, and vascular biology 2001
ApoA-II expression in CETP transgenic mice increases VLDL production and impairs VLDL clearance
JC Escolà-Gil, J Julve, À Marzal-Casacuberta, J Ordóñez-Llanos, F González-Sastre, F Blanco-Vaca
Journal of lipid research 2001
The OSBP-related protein family in humans
M Lehto, S Laitinen, G Chinetti, M Johansson, C Ehnholm, B Staels, E Ikonen, VM Olkkonen
Journal of lipid research 2001
Molecular link between cholesterol, cytokines and atherosclerosis
D Kaul
Molecular and Cellular Biochemistry 2001
Tangier disease and ABCA1
J Oram
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2000
Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein
S Yamashita
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2000
Cholesteryl ester transfer protein and atherosclerosis
A Inazu, J Koizumi, H Mabuchi
Current Opinion in Lipidology 2000
Nuclear receptors in metabolic diseases
R Mukherjee, JA Saye, PR Young
Expert Opinion on Therapeutic Targets 2000
Pros and cons of inhibiting cholesteryl ester transfer protein
K Hirano, S Yamashita, Y Matsuzawa
Current Opinion in Lipidology 2000
Prevention of coronary heart disease by raising high-density lipoprotein cholesterol?
A Eckardstein, G Assmann
Current Opinion in Lipidology 2000
Role of LXRs in control of lipogenesis
JR Schultz, H Tu, A Luk, JJ Repa, JC Medina, L Li, S Schwendner, S Wang, M Thoolen, DJ Mangelsdorf, KD Lustig, B Shan
Genes & development 2000
Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta
JJ Repa, G Liang, J Ou, Y Bashmakov, JM Lobaccaro, I Shimomura, B Shan, MS Brown, JL Goldstein, DJ Mangelsdorf
Genes & development 2000
Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha
A Venkateswaran, BA Laffitte, SB Joseph, PA Mak, DC Wilpitz, PA Edwards, P Tontonoz
Proceedings of the National Academy of Sciences 2000
ABC1 Gene Expression and ApoA-I-Mediated Cholesterol Efflux Are Regulated by LXR
K Schwartz, RM Lawn, DP Wade
Biochemical and Biophysical Research Communications 2000
The important role of residue F268 in ligand binding by LXRβ
F Urban, G Cavazos, J Dunbar, B Tan, P Escher, S Tafuri, M Wang
FEBS Letters 2000
Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor
JJ Repa, SD Turley, JA Lobaccaro, J Medina, L Li, K Lustig, B Shan, RA Heyman, JM Dietschy, DJ Mangelsdorf
The Journal of biological chemistry 2000
1999 George Lyman Duff memorial lecture: lipid transfer proteins, HDL metabolism, and atherogenesis
AR Tall, X Jiang, Y Luo, D Silver
Arteriosclerosis, thrombosis, and vascular biology 2000
Thyroid Hormone Stimulates Acetyl-CoA Carboxylase-α Transcription in Hepatocytes by Modulating the Composition of Nuclear Receptor Complexes Bound to a Thyroid Hormone Response Element
Y Zhang, L Yin, FB Hillgartner
The Journal of biological chemistry 2000
‘Orphans’ meet cholesterol
AR Tall, P Costet, Y Luo
Nature Medicine 2000
A, B, C…γ!
AR Tall, CW Schindler
Arteriosclerosis, thrombosis, and vascular biology 2000
Cholestenoic Acid Is a Naturally Occurring Ligand for Liver X Receptor α**This work was supported by NIH grants
C Song, S Liao
Endocrinology 2000
Advances in Molecular and Cellular Endocrinology
MR Pollak, EM Brown
Advances in Molecular and Cellular Endocrinology 1997
Identification of negative and positive regulatory elements in the human renin gene
LM Anderson, SE Choe, RY Yukhananov, RL Hopfner, GM Church, RE Pratt, VJ Dzau
The Journal of biological chemistry 1989

← Previous 1 2 3 … 11 12 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 patents
69 readers on Mendeley
See more details